Pliant Therapeutics
Colin Magowan has extensive experience in business development and strategy roles. Colin is currently a Senior Director of Business Development at Pliant Therapeutics, where they previously held the position of Director of Business Development. Prior to this, they served as the Vice President of Business Development at Virion Therapeutics, LLC. Colin also has experience as a Managing Member at CSM Consulting, LLC and as the VP of Strategy at CapGenic Advisors, LLC. In addition, they have held positions in alliance management and business development at Immunomic Therapeutics, Inc. Furthermore, Colin has worked as an advisor at KleenSpeed Technologies and as an Operations Manager at Fortune Hanebrink. Colin began their career as a Research Scientist at Reed College, focusing on spider embryology research.
Colin Magowan received their B.A. in Biology from Reed College, where they studied from 2002 to 2006.
This person is not in any offices
Pliant Therapeutics
Pliant is advancing drug development programs targeting a range of fibrotic diseases, with a focus on fibrotic tissue-specific inhibition of integrins and the TGF-β pathway.